Comparable composite endpoints after HLA-matched and HLA-haploidentical transplantation with post-transplantation cyclophosphamide
Shannon R. McCurdy(Hospital of the University of Pennsylvania), Leo Luznik(Johns Hopkins University), Gary L. Rosner(Johns Hopkins University), Heather J. Symons(Johns Hopkins University), B. Douglas Smith(Johns Hopkins University), Maria Bettinotti(Johns Hopkins University), William Matsui(The University of Texas at Austin), Ivan Borrello(Tampa General Hospital), Amy E. DeZern(Johns Hopkins University), Richard J. Jones(Sidney Kimmel Comprehensive Cancer Center), Jennifer A. Kanakry(National Institutes of Health), Keith W. Pratz(University of Pennsylvania), Ivana Gojo(Johns Hopkins University), Yvette L. Kasamon(Johns Hopkins University), Ephraim J. Fuchs(Johns Hopkins University), Richard F. Ambinder(Johns Hopkins University), Christopher G. Kanakry(National Cancer Institute), Robert A. Brodsky(Johns Hopkins University), Carol Ann Huff(Sidney Kimmel Comprehensive Cancer Center), Mark J. Levis(Sidney Kimmel Cancer Center), Margaret M. Showel(Johns Hopkins University), Hua-Ling Tsai(Johns Hopkins University), Douglas E. Gladstone(Northwell Health), Lode J. Swinnen(Johns Hopkins University), Javier Bolaños‐Meade(Johns Hopkins University)
Cited by 187
Related Papers
Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
|New England Journal of Medicine|2018|2.1k
HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide
|Biology of Blood and Marrow Transplantation|2008|1.9k
The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria
|New England Journal of Medicine|2006|1.3k